|  Help  |  About  |  Contact Us

Publication : In vivo alterations in calcium buffering capacity in transgenic mouse model of synucleinopathy.

First Author  Reznichenko L Year  2012
Journal  J Neurosci Volume  32
Issue  29 Pages  9992-8
PubMed ID  22815513 Mgi Jnum  J:186464
Mgi Id  MGI:5432409 Doi  10.1523/JNEUROSCI.1270-12.2012
Citation  Reznichenko L, et al. (2012) In vivo alterations in calcium buffering capacity in transgenic mouse model of synucleinopathy. J Neurosci 32(29):9992-8
abstractText  Abnormal accumulation of alpha-synuclein is centrally involved in the pathogenesis of many disorders with Parkinsonism and dementia. Previous in vitro studies suggest that alpha-synuclein dysregulates intracellular calcium. However, it is unclear whether these alterations occur in vivo. For this reason, we investigated calcium dynamics in transgenic mice expressing human WT alpha-synuclein using two-photon microscopy. We imaged spontaneous and stimulus-induced neuronal activity in the barrel cortex. Transgenic mice exhibited augmented, long-lasting calcium transients characterized by considerable deviation from the exponential decay. The most evident pathology was observed in response to a repetitive stimulation in which subsequent stimuli were presented before relaxation of calcium signal to the baseline. These alterations were detected in the absence of significant increase in neuronal spiking response compared with age-matched controls, supporting the possibility that alpha-synuclein promoted alterations in calcium dynamics via interference with intracellular buffering mechanisms. The characteristic shape of calcium decay and augmented response during repetitive stimulation can serve as in vivo imaging biomarkers in this model of neurodegeneration, to monitor progression of the disease and screen candidate treatment strategies.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

6 Bio Entities

0 Expression